Results 21 to 30 of about 459,821 (133)

Structural and Functional Characterization of N-Glycanase-1 Pathogenic Variants [PDF]

open access: yesCells
NGLY1 deficiency is a congenital disorder of deglycosylation, caused by pathogenic variants of the NGLY1 gene. It manifests as global developmental delay, hypo- or alacrima, hypotonia, and a primarily hyperkinetic movement disorder.
Antje Banning   +6 more
doaj   +3 more sources

Development of New NGLY1 Assay Systems – Toward Developing an Early Screening Method for NGLY1 Deficiency [PDF]

open access: yesGlycobiology
Abstract Cytosolic peptide: N-glycanase (PNGase/NGLY1 in mammals) is an amidase (EC:3.5.1.52) widely conserved in eukaryotes. It catalyzes the removal of N-glycans on glycoproteins, converting N-glycosylated Asn into Asp residues. This enzyme also plays a role in the quality control system for nascent glycoproteins.
Tadashi Suzuki   +2 more
exaly   +4 more sources

Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene. [PDF]

open access: yesPLoS Genetics, 2017
The cytoplasmic peptide:N-glycanase (Ngly1 in mammals) is a de-N-glycosylating enzyme that is highly conserved among eukaryotes. It was recently reported that subjects harboring mutations in the NGLY1 gene exhibited severe systemic symptoms (NGLY1 ...
Haruhiko Fujihira   +12 more
doaj   +3 more sources

MRI Characterization of Structural Brain Abnormalities in NGLY1 Deficiency. [PDF]

open access: yesInt J Dev Neurosci
Structural MRI from 11 patients with NGLY1 deficiency, an ultrarare neurodevelopmental disorder, revealed reduced subcortical volume (thalamus and putamen) across ages and reduced cortical surface area in younger patients. These measures tracked with clinical features such as seizures and gait disturbance, supporting brain imaging as a candidate ...
Dennis EL   +8 more
europepmc   +3 more sources

NGLY1 deficiency: Novel variants and literature review

open access: yesEuropean Journal of Medical Genetics, 2021
NGLY1 deficiency is a recently described autosomal recessive disorder, involved in deglycosylation of proteins, and for that reason grouped as the congenital disorders of deglycosylation together with the lysosomal storage disorders. The typical phenotype is characterized by intellectual disability, liver malfunctioning, muscular hypotonia, involuntary
Ariana Kariminejad   +9 more
core   +5 more sources

Correction to: Reversibility of motor dysfunction in the rat model of NGLY1 deficiency [PDF]

open access: yesMolecular Brain, 2021
Makoto Asahina   +5 more
doaj   +4 more sources

Urine Oligosaccharide Screening by MALDI-TOF for the Identification of NGLY1 Deficiency [PDF]

open access: yesMolecular Genetics and Metabolism, 2018
N-glycanase deficiency (NGLY1 deficiency, NGLY1-CDDG), the first autosomal recessive congenital disorder of N-linked deglycosylation (CDDG), is caused by pathogenic variants in NGLY1. The majority of affected individuals have been identified using exome or genome sequencing.
Gerard Berry   +2 more
exaly   +4 more sources

N‐glycoproteomics reveals distinct glycosylation alterations in NGLY1‐deficient patient‐derived dermal fibroblasts

open access: yesJournal of Inherited Metabolic Disease, Volume 46, Issue 1, Page 76-91, January 2023., 2023
Abstract Congenital disorders of glycosylation are genetic disorders that occur due to defects in protein and lipid glycosylation pathways. A deficiency of N‐glycanase 1, encoded by the NGLY1 gene, results in a congenital disorder of deglycosylation.
Rohit Budhraja   +8 more
wiley   +2 more sources

Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene

open access: yesStem Cell Research, 2019
NGLY1 deficiency is a rare genetic disease caused by mutations in the NGLY1 gene that encodes N-glycanase 1. The disease phenotype in patient cells is unclear.
Rong Li   +11 more
doaj   +2 more sources

Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation [PDF]

open access: yeseLife, 2020
During endoplasmic reticulum-associated degradation (ERAD), the cytoplasmic enzyme N-glycanase 1 (NGLY1) is proposed to remove N-glycans from misfolded N-glycoproteins after their retrotranslocation from the ER to the cytosol. We previously reported that
Antonio Galeone   +13 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy